Fordeling Binding af sunitinib og dets aktive hovedmetabolit til human plasmaprotein er i in vitro undersøgelser henholdsvis 95% og 90%, og der er tilsyneladende ingen koncentrationsafhængighed.
Distribution Binding of sunitinib and its primary active metabolite to human plasma protein in in vitro assays was 95% and 90%, respectively, with no apparent concentration dependence.